(S)-Hydroxychloroquine sulfate
- CAS No.
- 155204-09-4
- Chemical Name:
- (S)-Hydroxychloroquine sulfate
- Synonyms
- (S)-Hydroxychloroquine sulfate;2-[[(4S)-4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-ethanol, monosulfate
- CBNumber:
- CB29739367
- Molecular Formula:
- C18H28ClN3O5S
- Molecular Weight:
- 433.95
- MDL Number:
- MOL File:
- 155204-09-4.mol
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302+H312+H332-H315-H319 | |||||||||
| Precautionary statements | P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P501 | |||||||||
| NFPA 704 |
|
(S)-Hydroxychloroquine sulfate price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 33443 | (S)-Hydroxychloroquine (sulfate) ≥95% | 155204-09-4 | 500μg | $134 | 2026-04-30 | Buy |
| Cayman Chemical | 33443 | (S)-Hydroxychloroquine (sulfate) ≥95% | 155204-09-4 | 1mg | $253 | 2026-04-30 | Buy |
| Biosynth | FGA20409 | (S)-Hydroxychloroquine sulfate | 155204-09-4 | 5mg | $1434.3 | 2026-06-04 | Buy |
| Biosynth | FGA20409 | (S)-Hydroxychloroquine sulfate | 155204-09-4 | 10mg | $2294.9 | 2026-06-04 | Buy |
| Biosynth | FGA20409 | (S)-Hydroxychloroquine sulfate | 155204-09-4 | 25mg | $4302.75 | 2026-06-04 | Buy |
(S)-Hydroxychloroquine sulfate Chemical Properties, Uses, Production
Uses
(S)-Hydroxychloroquine ((S)-HCQ) sulfate is an isomer of Hydroxychloroquine (HY-W031727). (S)-Hydroxychloroquine sulfate (2.5-20 mg/mL) reduces the rate of insulin degradation in liver homogenates isolated from non-diabetic and diabetic rats. Formulations containing Hydroxychloroquine have been used in the study of malaria, rheumatoid arthritis, and systemic lupus erythematosus[1].
Biological Activity
(S)-Hydroxychloroquine is an isomer of hydroxychloroquine .1 (S)-Hydroxychloroquine (2.5-20 mg/ml) reduces the rate of insulin degradation in isolated liver homogenates from non-diabetic and diabetic rats. Formulations containing hydroxychloroquine have been used in the prevention or treatment of malaria, as well as in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
References
1.Emami, J., Pasutto, F.M., Mercer, J.R., et al.Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic ratsLife Sci.64(5)325-335(1999)
(S)-Hydroxychloroquine sulfate Preparation Products And Raw materials
Raw materials
Preparation Products
(S)-Hydroxychloroquine sulfate Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ChemeGen | 18818260767 | 2625930290@qq.com | China | 6966 | 58 |
| Foshan Heshuo Pharm technology Co., ltd | 15363639686 | heshuoyiyao@hotmail.com | China | 2488 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| TLC Pharmaceutical Standards Ltd. | 18012923235 | chinasales04@tlcstandards.com.cn | China | 8143 | 58 |
| TargetMol | 400-821-0310 15002144251 | xuexiang.shao@tsbiochem.com | China | 29128 | 58 |
| Supplier | Advantage |
|---|---|
| ChemeGen | 58 |
| Foshan Heshuo Pharm technology Co., ltd | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 58 |
| TLC Pharmaceutical Standards Ltd. | 58 |
| TargetMol | 58 |
